Harrow, Inc. (HROW)
39.80
-1.15
(-2.81%)
USD |
NASDAQ |
Aug 24, 16:00
39.78
-0.02
(-0.05%)
After-Hours: 20:00
Harrow Shareholders Equity (Quarterly) : 15.20M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 15.20M |
| March 31, 2026 | 28.71M |
| December 31, 2025 | 52.45M |
| September 30, 2025 | 47.02M |
| June 30, 2025 | 49.65M |
| March 31, 2025 | 56.45M |
| December 31, 2024 | 69.65M |
| September 30, 2024 | 57.60M |
| June 30, 2024 | 58.08M |
| March 31, 2024 | 60.09M |
| December 31, 2023 | 70.36M |
| September 30, 2023 | 75.76M |
| June 30, 2023 | 22.41M |
| March 31, 2023 | 21.88M |
| December 31, 2022 | 27.60M |
| September 30, 2022 | 1.217M |
| June 30, 2022 | 5.749M |
| March 31, 2022 | 10.09M |
| December 31, 2021 | 11.29M |
| September 30, 2021 | 16.59M |
| June 30, 2021 | 23.20M |
| March 31, 2021 | 28.22M |
| December 31, 2020 | 27.18M |
| September 30, 2020 | 25.28M |
| June 30, 2020 | 15.73M |
| Date | Value |
|---|---|
| March 31, 2020 | 15.34M |
| December 31, 2019 | 27.71M |
| September 30, 2019 | 23.96M |
| June 30, 2019 | 35.06M |
| March 31, 2019 | 37.06M |
| December 31, 2018 | 24.75M |
| September 30, 2018 | 4.453M |
| June 30, 2018 | 3.732M |
| March 31, 2018 | 0.083M |
| December 31, 2017 | 2.615M |
| September 30, 2017 | 3.746M |
| June 30, 2017 | 7.646M |
| March 31, 2017 | 5.317M |
| December 31, 2016 | 6.432M |
| September 30, 2016 | 2.832M |
| June 30, 2016 | 5.608M |
| March 31, 2016 | 8.784M |
| December 31, 2015 | -1.385M |
| September 30, 2015 | 2.244M |
| June 30, 2015 | 5.24M |
| March 31, 2015 | 6.206M |
| December 31, 2014 | 8.150M |
| September 30, 2014 | 10.28M |
| June 30, 2014 | 12.04M |
| March 31, 2014 | 13.80M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Viatris, Inc. | 14.26B |
| Zevra Therapeutics, Inc. | 217.65M |
| Indivior Pharmaceuticals, Inc. | -208.00M |
| Liquidia Corp. | 195.11M |
| 60 Degrees Pharmaceuticals, Inc. | 2.614M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 416.82M |
| Total Liabilities (Quarterly) | 401.97M |
| Debt to Equity Ratio | 19.79 |
| Current Ratio | 2.244 |
| Net Debt Paydown Yield | -0.89% |